CN105326939A - Traditional Chinese medicine for treating heart and cerebral vusculer diseases - Google Patents
Traditional Chinese medicine for treating heart and cerebral vusculer diseases Download PDFInfo
- Publication number
- CN105326939A CN105326939A CN201510871232.9A CN201510871232A CN105326939A CN 105326939 A CN105326939 A CN 105326939A CN 201510871232 A CN201510871232 A CN 201510871232A CN 105326939 A CN105326939 A CN 105326939A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- cardiovascular
- cerebrovascular disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicine, and particularly relates to a traditional Chinese medicine for treating heart and cerebral vusculer diseases. The traditional Chinese medicine for treating heart and cerebral vusculer diseases is prepared from, by weight, 18-36 parts of the root of red-rooted salvia, 9-17 parts of the rhizome of chuanxiong, 12-24 parts of milkvetch roots, 15-20 parts of peach kernels, 15-20 parts of lumbricus, 10-20 parts of hawthorn fruits, 15-20 parts of musk, 10-20 parts of leech, 6-12 parts of ground beeltle, 20-30 parts of pubescent holly roots and 10-20 parts of pseudo-ginseng. The medicinal materials are matched, bring out the best in one another and achieve the effects of tonifying Qi, activating blood, removing blood stasis and clearing and activating the channels and collaterals, and the traditional Chinese medicine is widely used for treating heart and cerebral vusculer diseases.
Description
Technical field
The invention belongs to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof.
Background technology
At present, cardiovascular and cerebrovascular disease is the disease that a kind of disability rate is high.Once this kind of disease must be gone up, oneself be difficult to take care of oneself, cause very large financial burden and mental pressure to family.Patient oneself is also usually because tied down household, and mood is not smooth, have impact on the treatment of disease on the contrary.For cardiovascular and cerebrovascular disease, be no matter economically, family's angle, or from health perspectives, have prevention only and be only completely safe plan, brilliant act.Prevention in early one day, earlier feels at ease.The Chinese medicinal formulae of middle treatment cardiovascular and cerebrovascular disease, recipe drug is processed at one tens taste raw material of Chinese medicine, and prescription is large, and compatibility amount is complicated, and cost is high, has side effects many, gives the problem that patient brings financial burden overweight.
Summary of the invention
Object of the present invention, is to provide a kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease and preparation method thereof, it be Chinese medicine primarily of Radix Salviae Miltiorrhizae, Radix Notoginseng, Rhizoma Chuanxiong, the Radix Astragali, Semen Persicae, Pheretima, Fructus Crataegi, Moschus, Hirudo, Eupolyphaga Seu Steleophaga, Radix Ilicis Pubescentis, Radix Notoginseng raw material of Chinese medicine is through extraction, micronization, and processing and refining forms.
A kind of Chinese medicine for the treatment of cardiovascular and cerebrovascular disease, be made up of following component by weight: Radix Salviae Miltiorrhizae 18-36 part, Rhizoma Chuanxiong 9-17 part, Radix Astragali 12-24 part, Semen Persicae 15-20 part, Pheretima 15-20 part, Fructus Crataegi 10-20 part, Moschus 15-20 part, Hirudo 10-20 part, Eupolyphaga Seu Steleophaga 6-12 part, Radix Ilicis Pubescentis 20-30 part, Radix Notoginseng 10-20 part.
The Chinese medicine of described treatment cardiovascular and cerebrovascular disease, be made up of following component by weight: Radix Salviae Miltiorrhizae 25-30 part, Rhizoma Chuanxiong 11-15 part, Radix Astragali 15-20 part, Semen Persicae 17-19 part, Pheretima 17-19 part, Fructus Crataegi 13-17 part, Moschus 17-19 part, Hirudo 13-17 part, Eupolyphaga Seu Steleophaga 7-11 part, Radix Ilicis Pubescentis 23-27 part, Radix Notoginseng 13-17 part.
The Chinese medicine of described treatment cardiovascular and cerebrovascular disease, is made up of following component by weight: Radix Salviae Miltiorrhizae 27 parts, Rhizoma Chuanxiong 13 parts, the Radix Astragali 17 parts, 18 parts, Semen Persicae, Pheretima 18 parts, Fructus Crataegi 15 parts, 18 parts, Moschus, Hirudo 15 parts, Eupolyphaga Seu Steleophaga 9 parts, Radix Ilicis Pubescentis 25 parts, Radix Notoginseng 15 parts.
Described form of Chinese drug is capsule; Granule or tablet.
Treat a Chinese medicinal preparation method for cardiovascular and cerebrovascular disease, concrete steps are: (1) prepares burden by above-mentioned weight portion;
(2) by Radix Notoginseng grinds, sieve for subsequent use;
(3) by Moschus grinds, sieve for subsequent use;
(3) by Eupolyphaga Seu Steleophaga, Pheretima, Hirudo mixes, grinds, sieves for subsequent use;
(4) by remaining Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, the Radix Astragali, Semen Persicae, Fructus Crataegi, Radix Ilicis Pubescentis steeps 0.5-1 in water individual hour, and then half an hour is endured out in big fire; Filter; Medicinal residues after filtering are continued to add water, endure 1 hour, after twice filtrate is merged; Add Eupolyphaga Seu Steleophaga successively, Rhizoma Chuanxiong, the powder of Hirudo mixing polishing; Add Moschus powder again; Finally put into Radix Notoginseng powder; Mix homogeneously, to obtain final product.
Add appropriate pharmaceutic adjuvant tabletted and namely obtain tablet, or add appropriate pharmaceutic adjuvant and make granule and namely obtain granule.
The main Prescription Effect of Chinese medicine: Radix Notoginseng: sweet, the micro-hardship of nature and flavor, temperature, returns liver, stomach warp, the hemostasis of function dissipating blood stasis, subduing swelling and relieving pain; Radix Salviae Miltiorrhizae: nature and flavor are bitter, be slightly cold, GUIXIN, Liver Channel, function stasis-dispelling and pain-killing, promoting blood circulation to restore menstrual flow, clear away heart-fire relieving restlessness; Hirudo: nature and flavor are salty, bitter, flat, returns Liver Channel, function removing blood stasis, removing blood stasis, stimulates the menstrual flow; Eupolyphaga Seu Steleophaga: nature and flavor are salty, cold, return Liver Channel, function removing blood stasis with potent drugs blood, reuniting the fractured tendons and bones; Pheretima: Pheretima is cold in nature, salty in the mouth.Function: heat clearing away, suppressing the hyperactive liver, Zhichuan, dredging collateral.Return liver, stomach, lung, urinary bladder channel.Function heat clearing away suppressing the hyperactive liver, relieving spasm by subduing liver-wind, relieving asthma, diuresis, dredging collateral eliminating impediment; Semen Persicae sugariness is bitter, enters lung, flat, liver, large intestine channel; There is blood stasis removing and clots absorbing, moisturize effect of laxation; Control amenorrhea, dysmenorrhea, abdominal mass abdominal mass mass in the abdomen, traumatic injury, dryness of the intestine constipation; Moschus acrid in the mouth, warm in nature; GUIXIN, liver, spleen channel; Fragrant strongly alter loose, can rise and can fall, there is refreshment of having one's ideas straightened out, blood circulation promoting and dispersing pathogen accumulation, alleviating pain and detumescence, expedite the emergence of effect of lower tire; Above-mentioned drug matching, brings out the best in each other, and gathers effect of Yiqi-Huoxue-Huayu the meridian dredging altogether.
The invention has the beneficial effects as follows: Chinese medicine is primarily of Radix Salviae Miltiorrhizae, Radix Notoginseng, Rhizoma Chuanxiong, the Radix Astragali, Semen Persicae, and Pheretima, Fructus Crataegi, Moschus, Hirudo, Eupolyphaga Seu Steleophaga, Radix Ilicis Pubescentis, Radix Notoginseng raw material of Chinese medicine is through extraction, micronization, and processing and refining forms.Its dosage form comprises capsule, tablet, granule.All medicines match, and bring out the best in each other, and gather effect of Yiqi-Huoxue-Huayu the meridian dredging altogether, and for the treatment of cardiovascular and cerebrovascular disease, have significant effect, total effective rate reaches 97.73%.
model case:
Zhao so-and-so, occupation: teacher; Threescore, has the household heredity factors of cardiovascular and cerebrovascular disease: symptom: emergent breast left part pain time tired or nervous, emits to shoulder, arm or cervical region with perspiration or pain; Feel during sleep to feel suffocated, just take a turn for the better after needing high pillow; Repeatedly occur that pulse is uneven, bradycardia; Than others easier chest distress and palpitation symptoms and with hypomnesis time upstairs.Have dizziness, slowness of thinking, general weakness, nervous, bradykinesia, behavior be inmature, etc. symptom; Take medicine after the course for the treatment of, sensation is significantly improved:
dizzy situation disappears, and left chest pain disappears, and speed aroused in interest is delayed normally by crossing.
" according to GCP " and " new Chinese medicine guideline of clinical investigations ", Chinese medicine of the present invention has carried out the clinical research for the treatment of cardiovascular and cerebrovascular disease.Data and method: Chinese drug-treated group 132 of the present invention example, wherein man 62 example, female 60 example, age 46-65 year, 53 years old mean age, stadium 6 months to 10 years.With three Zhou Weiyi the course for the treatment of, be used in conjunction two courses for the treatment of, follow up a case by regular visits to 3 months.Found that: treatment by Chinese herbs group 132 of the present invention example, clinical recovery 105 example, effective 13 examples, effective 11 examples, always effective 97.73%.Conclusion, Chinese medicine of the present invention has significant curative effect to cardiovascular and cerebrovascular disease.
Detailed description of the invention:
embodiment 1
Treat a Chinese medicine for cardiovascular and cerebrovascular disease, it is made up of following component by weight:
Radix Salviae Miltiorrhizae 18 parts, Rhizoma Chuanxiong 9 parts, the Radix Astragali 12 parts, 15 parts, Semen Persicae, Pheretima 15 parts, Fructus Crataegi 10 parts, 15 parts, Moschus, Hirudo 10 parts, Eupolyphaga Seu Steleophaga 6 parts, Radix Ilicis Pubescentis 20 parts, Radix Notoginseng 10 parts.
Its preparation technology is:
Treat a Chinese medicinal preparation method for cardiovascular and cerebrovascular disease, concrete steps are: (1) prepares burden by above-mentioned weight portion;
(2) by Radix Notoginseng grinds, sieve for subsequent use;
(3) by Moschus grinds, sieve for subsequent use;
(3) by Eupolyphaga Seu Steleophaga, Pheretima, Hirudo mixes, grinds, sieves for subsequent use;
(4) by remaining Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, the Radix Astragali, Semen Persicae, Fructus Crataegi, Radix Ilicis Pubescentis steeps 0.5-1 in water individual hour, and then half an hour is endured out in big fire; Filter; Medicinal residues after filtering are continued to add water, endure 1 hour, after twice filtrate is merged; Add Eupolyphaga Seu Steleophaga successively, Rhizoma Chuanxiong, the powder of Hirudo mixing polishing; Add Moschus powder again; Finally put into Radix Notoginseng powder; Mix homogeneously, to obtain final product.
Add appropriate pharmaceutic adjuvant tabletted and namely obtain tablet, or add appropriate pharmaceutic adjuvant and make granule and namely obtain granule.
embodiment 2
Treat a Chinese medicine for cardiovascular and cerebrovascular disease, it is made up of following component by weight:
Radix Salviae Miltiorrhizae 136 parts, Rhizoma Chuanxiong 17 parts, the Radix Astragali 24 parts, 20 parts, Semen Persicae, Pheretima 20 parts, Fructus Crataegi 20 parts, 20 parts, Moschus, Hirudo 20 parts, Eupolyphaga Seu Steleophaga 12 parts, Radix Ilicis Pubescentis 30 parts, Radix Notoginseng 20 parts.
Preparation technology is with embodiment 1.
embodiment 3
Treat a Chinese medicine for cardiovascular and cerebrovascular disease, it is made up of following component by weight:
Radix Salviae Miltiorrhizae 25 parts, Rhizoma Chuanxiong 11 parts, the Radix Astragali 15 parts, 17 parts, Semen Persicae, Pheretima 17 parts, Fructus Crataegi 13 parts, 17 parts, Moschus, Hirudo 13 parts, Eupolyphaga Seu Steleophaga 7 parts, Radix Ilicis Pubescentis 23 parts, Radix Notoginseng 13 parts.
Preparation technology is with embodiment 1.
embodiment 4
Treat a Chinese medicine for cardiovascular and cerebrovascular disease, it is made up of following component by weight:
Radix Salviae Miltiorrhizae 30 parts, Rhizoma Chuanxiong 15 parts, the Radix Astragali 20 parts, 19 parts, Semen Persicae, Pheretima 19 parts, Fructus Crataegi 17 parts, 19 parts, Moschus, Hirudo 17 parts, Eupolyphaga Seu Steleophaga 11 parts, Radix Ilicis Pubescentis 27 parts, Radix Notoginseng 17 parts.
Preparation technology is with embodiment 1.
embodiment 5
The Chinese medicine for the treatment of cardiovascular and cerebrovascular disease as claimed in claim 1, it is made up of following component by weight: Radix Salviae Miltiorrhizae 27 parts, Rhizoma Chuanxiong 13 parts, the Radix Astragali 17 parts, 18 parts, Semen Persicae, Pheretima 18 parts, Fructus Crataegi 15 parts, 18 parts, Moschus, Hirudo 15 parts, Eupolyphaga Seu Steleophaga 9 parts, Radix Ilicis Pubescentis 25 parts, Radix Notoginseng 15 parts.
Preparation technology is with embodiment 1.
Claims (8)
1. treat the Chinese medicine of cardiovascular and cerebrovascular disease for one kind, it is characterized in that: be made up of following component by weight: Radix Salviae Miltiorrhizae 18-36 part, Rhizoma Chuanxiong 9-17 part, Radix Astragali 12-24 part, Semen Persicae 15-20 part, Pheretima 15-20 part, Fructus Crataegi 10-20 part, Moschus 15-20 part, Hirudo 10-20 part, Eupolyphaga Seu Steleophaga 6-12 part, Radix Ilicis Pubescentis 20-30 part, Radix Notoginseng 10-20 part.
2. the Chinese medicine for the treatment of cardiovascular and cerebrovascular disease as claimed in claim 1, it is characterized in that: be made up of following component by weight: Radix Salviae Miltiorrhizae 25-30 part, Rhizoma Chuanxiong 11-15 part, Radix Astragali 15-20 part, Semen Persicae 17-19 part, Pheretima 17-19 part, Fructus Crataegi 13-17 part, Moschus 17-19 part, Hirudo 13-17 part, Eupolyphaga Seu Steleophaga 7-11 part, Radix Ilicis Pubescentis 23-27 part, Radix Notoginseng 13-17 part.
3. the Chinese medicine for the treatment of cardiovascular and cerebrovascular disease as claimed in claim 1, it is characterized in that: be made up of following component by weight: Radix Salviae Miltiorrhizae 27 parts, Rhizoma Chuanxiong 13 parts, the Radix Astragali 17 parts, 18 parts, Semen Persicae, Pheretima 18 parts, Fructus Crataegi 15 parts, 18 parts, Moschus, Hirudo 15 parts, Eupolyphaga Seu Steleophaga 9 parts, Radix Ilicis Pubescentis 25 parts, Radix Notoginseng 15 parts.
4. the Chinese medicine of the treatment cardiovascular and cerebrovascular disease as described in claim as arbitrary in claim 1-3, is characterized in that: described form of Chinese drug is capsule.
5. the Chinese medicine of the treatment cardiovascular and cerebrovascular disease as described in claim as arbitrary in claim 1-3, is characterized in that: described form of Chinese drug is granule.
6. the Chinese medicine of the treatment cardiovascular and cerebrovascular disease as described in claim as arbitrary in claim 1-3, is characterized in that: described form of Chinese drug is tablet.
7. a kind of Chinese medicinal preparation method for the treatment of cardiovascular and cerebrovascular disease according to claim 1, is characterized in that: concrete steps are: (1) prepares burden by above-mentioned weight portion;
(2) by Radix Notoginseng grinds, sieve for subsequent use;
(3) by Moschus grinds, sieve for subsequent use;
(3) by Eupolyphaga Seu Steleophaga, Pheretima, Hirudo mixes, grinds, sieves for subsequent use;
(4) by remaining Radix Salviae Miltiorrhizae, Rhizoma Chuanxiong, the Radix Astragali, Semen Persicae, Fructus Crataegi, Radix Ilicis Pubescentis steeps 0.5-1 in water individual hour, and then half an hour is endured out in big fire; Filter; Medicinal residues after filtering are continued to add water, endure 1 hour, after twice filtrate is merged; Add Eupolyphaga Seu Steleophaga successively, Rhizoma Chuanxiong, the powder of Hirudo mixing polishing; Add Moschus powder again; Finally put into Radix Notoginseng powder; Mix homogeneously, to obtain final product.
8. a kind of Chinese medicinal preparation method for the treatment of cardiovascular and cerebrovascular disease as claimed in claim 7, is characterized in that: add appropriate pharmaceutic adjuvant tabletted and namely obtain tablet, or adds appropriate pharmaceutic adjuvant and make granule and namely obtain granule.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510871232.9A CN105326939A (en) | 2015-12-02 | 2015-12-02 | Traditional Chinese medicine for treating heart and cerebral vusculer diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510871232.9A CN105326939A (en) | 2015-12-02 | 2015-12-02 | Traditional Chinese medicine for treating heart and cerebral vusculer diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105326939A true CN105326939A (en) | 2016-02-17 |
Family
ID=55277845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510871232.9A Withdrawn CN105326939A (en) | 2015-12-02 | 2015-12-02 | Traditional Chinese medicine for treating heart and cerebral vusculer diseases |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105326939A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105920375A (en) * | 2016-07-06 | 2016-09-07 | 贾庭山 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine |
CN106938048A (en) * | 2017-04-11 | 2017-07-11 | 王敬顺 | A kind of Chinese medicine preparation for treating cardiovascular and cerebrovascular disease |
CN107375562A (en) * | 2017-08-09 | 2017-11-24 | 裴然 | A kind of Chinese medicine and boiling method of effectively treatment cardiovascular and cerebrovascular disease |
-
2015
- 2015-12-02 CN CN201510871232.9A patent/CN105326939A/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
黎利芬等: "黄芪活血汤治疗脑梗死急性期158例疗效观察", 《中国中医急症》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105920375A (en) * | 2016-07-06 | 2016-09-07 | 贾庭山 | Traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and preparation method of traditional Chinese medicine |
CN106938048A (en) * | 2017-04-11 | 2017-07-11 | 王敬顺 | A kind of Chinese medicine preparation for treating cardiovascular and cerebrovascular disease |
CN107375562A (en) * | 2017-08-09 | 2017-11-24 | 裴然 | A kind of Chinese medicine and boiling method of effectively treatment cardiovascular and cerebrovascular disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101066303B (en) | Medicine for treating cerebral thrombus, cerebral angiosclerosis, apoplexy and hemiplegia and its preparation | |
CN103432390A (en) | Medicament for treating coronary heart disease and preparation method thereof | |
CN103977217A (en) | Medicinal composition for treating renal carcinoma | |
CN105326939A (en) | Traditional Chinese medicine for treating heart and cerebral vusculer diseases | |
CN103463607A (en) | Preparation method for medicament for treating postpartum disease | |
CN103566236A (en) | Traditional Chinese medicinal preparation for dispelling dampness and soothing channel | |
CN104491236A (en) | Traditional Chinese medicine preparation for treating essential hypertension and preparation method for traditional Chinese medicine preparation | |
CN104398980A (en) | Traditional Chinese medicine preparation for treating apoplectic hemiplegia and preparation method of traditional Chinese medicine preparation | |
CN103830436A (en) | Traditional Chinese medicine composition for treating hypertension and preparation method thereof | |
CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
CN103860773A (en) | Traditional Chinese medicine composition for treating myocardial ischemia and preparation method thereof | |
CN103285343A (en) | Medicine for treating liver cancer and preparation method thereof | |
CN103520352B (en) | The Chinese medicine for the treatment of stasis blocking venation pattern of syndrome obstruction of qi in the chest and cardialgia | |
CN102366469A (en) | Drug for treating leucoderma | |
CN105327157A (en) | Traditional Chinese medicine for treating cerebrovascular blockage and preparation method thereof | |
CN104800610A (en) | Traditional Chinese medicine preparation for treating Parkinson's disease and preparation method thereof | |
CN105327003A (en) | Traditional Chinese medicine for treating cardiovascular diseases and preparation method thereof | |
CN105326949A (en) | Traditional Chinese medicine for treating cardiovascular blockage and preparation method thereof | |
CN102743499A (en) | Chinese medicinal herb drug for treating soft tissue internal injury blood stasis and cerebral hemorrhage | |
CN103156979B (en) | A kind of dispelling speckles and whitening face medicine | |
CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
CN105079392A (en) | Preparation for treating ischialgia and preparation method thereof | |
CN105232772A (en) | Traditional Chinese medicine for treating cardiovascular diseases and preparing method of traditional Chinese medicine | |
CN104873780A (en) | Traditional Chinese medicine preparation for treating dysmenorrhea | |
CN105456743A (en) | Chinese medicine for treating cerebrovascular disease and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160217 |
|
WW01 | Invention patent application withdrawn after publication |